Screener
Sol-Gel Technologies
SLGLSol-Gel Technologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Moshe Arkin, with a market cap of $202.1M.
$202.14M+130%
We’re still putting together Sol-Gel Technologies’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Sol-Gel Technologies up the queue, and we’ll analyze its filings next.
Earnings
Q3 2026 report
November 12, 2026Next report
Date not yet announcedProfile
CountryIsrael
Listed2018
Employees36.0
CEOMoshe Arkin
SectorHealthcare
IndustryBiotechnology
Websitesol-gel.com
FilingsSEC EDGAR